Forte Biosciences, Inc.
FBRXOther · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Operating income | −$70.7M | −$36.6M | −$32.5M | −$13.9M | −$21.5M | −$46.3M |
| Net income | −$69.4M | −$35.5M | −$31.5M | −$13.9M | −$21.7M | −$46.5M |
| Total assets | $82.8M | $61.6M | $39.0M | $42.0M | $43.3M | $61.2M |
| Total liabilities | $21.8M | $9.1M | — | — | — | — |
| Equity | $61.0M | $52.5M | $35.3M | $38.8M | $41.5M | $59.0M |
| EPS (diluted) | $-4.71 | $-12.17 | $-24.92 | $-0.80 | $-1.55 | — |
| Shares out. | 6.6M | 36.4M | 21.0M | 14.8M | 13.5M | 23.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- −113.7%
- Return on assets
- −83.8%
- Return on capital (ROCE)
- −113.9%
- Liabilities / assets
- 26.3%
- Debt / equity
- 0.36×
- Book value / share
- $9.27
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -6.85distress
- Accruals / assets
- −22.3%clean
- Piotroski F-Score
- 2/7weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Mpm Bioimpact LlcPassive (13G)May 15, 2026
- Janus Henderson Group PlcPassive (13G)May 15, 2026
- Alger Associates IncPassive (13G)May 15, 2026
- Orbimed Advisors LlcPassive (13G)May 15, 2026
- Point72 Asset Management, L.P.Passive (13G)May 15, 2026
- Affinity Asset Advisors, LlcPassive (13G)May 14, 2026
- Adage Capital Management, L.P.Passive (13G)May 13, 2026
- Oliveira Steven MichaelPassive (13G)Jan 9, 2026
- Biotechnology Value Fund L PPassive (13G)Nov 14, 2025
- Federated Hermes, Inc.Passive (13G)Oct 7, 2025
- Ikarian Capital, LlcPassive (13G)Aug 14, 2025
- Boothbay Fund Management, LlcPassive (13G)Aug 7, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Riley Antony AOfficer — CHIEF FINANCIAL OFFICER | Apr 1, 2026 | Option exercise | 375 | — |
| Wagner Paul A.Officer — SEE REMARKS | Apr 1, 2026 | Option exercise | 1,250 | — |
| Wagner Paul A.Officer — SEE REMARKS | Jan 1, 2026 | Option exercise | 1,250 | $0.00 |
| Riley Antony AOfficer — CHIEF FINANCIAL OFFICER | Dec 30, 2025 | Buy | 9,680 | $26.33 |
| Riley Antony AOfficer — CHIEF FINANCIAL OFFICER | Oct 1, 2025 | Option exercise | 375 | $0.00 |
| Wagner Paul A.Officer — SEE REMARKS | Oct 1, 2025 | Option exercise | 1,250 | $0.00 |
| Riley Antony AOfficer — CHIEF FINANCIAL OFFICER | Jul 1, 2025 | Option exercise | 375 | $0.00 |
| Wagner Paul A.Officer — SEE REMARKS | Jul 1, 2025 | Option exercise | 1,250 | $0.00 |
| Riley Antony AOfficer — CHIEF FINANCIAL OFFICER | Apr 1, 2025 | Option exercise | 375 | $0.00 |
| Wagner Paul A.Officer — SEE REMARKS | Apr 1, 2025 | Option exercise | 1,250 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1.2M | 5.7 | +16.2% |
| Apr 30, 2026 | 1.0M | 4.4 | +22.9% |
| Apr 15, 2026 | 843,652 | 1.5 | -5.4% |
| Mar 31, 2026 | 892,176 | 3.5 | +22.7% |
| Mar 13, 2026 | 727,297 | 3.9 | +2.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 14, 2026
- Entered a material agreement · Regulation FD disclosure · Other material eventApr 9, 2026
- Results of operationsApr 1, 2026
- Results of operationsNov 14, 2025
- Results of operations · Other material eventAug 14, 2025
- Entered a material agreement · Other material eventJun 25, 2025
- Regulation FD disclosure · Other material eventJun 23, 2025
- Shareholder voteMay 30, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13GMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- SCHEDULE 13G/AMay 15, 2026
- 8-KMay 14, 2026
- SCHEDULE 13G/AMay 14, 2026
- SCHEDULE 13GMay 13, 2026
- 10-QMay 11, 2026
- ARSApr 29, 2026
- DEF 14AApr 29, 2026
- 424B5Apr 9, 2026
- 8-KApr 9, 2026
- 424B5Apr 8, 2026
- 4Apr 3, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.